Showing titles in Physical Illness & Disease

Dr. Ben Synth explores how GLP-1 drugs like Ozempic affect the brain beyond weight loss, examining emerging research on Alzheimer's protection, mental health impacts, and addiction treatment. Discover what the latest neuroscience reveals about these medications reshaping our understanding of brain health. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like Ozempic and Wegovy work at the cellular level to transform metabolism. Dr. Ben Synth breaks down the molecular mechanisms that slow digestion, rewire hunger signals in your brain, and regulate blood sugar through your pancreas—revealing the sophisticated biological cascade behind these groundbreaking treatments. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like semaglutide are revolutionizing kidney disease treatment, cutting risk by 24% in landmark trials. Join host Julia Cartwright as she uncovers the science, breakthrough research, and future of kidney protection for millions with chronic kidney disease. For more content like this, visit QuietPlease.ai

Confused about how to bring up Ozempic with your doctor without sounding pushy or uninformed? Julia Cartwright gives you the exact preparation steps, word-for-word scripts, and follow-up strategies to turn an awkward request into a confident, productive medical conversation that respects both your goals and your doctor's expertise. For more content like this, visit QuietPlease.ai

Dr. Ben Synth unpacks the SURMOUNT-5 trial results comparing tirzepatide and semaglutide head-to-head in the largest obesity drug study ever conducted. Discover what 751 patients taught us about weight loss efficacy, cardiovascular benefits, and real-world tolerability differences that are reshaping clinical practice. For more content like this, visit QuietPlease.ai

Eli Lilly's Zepbound delivers up to 21% weight loss through a groundbreaking dual-hormone mechanism that's reshaping obesity treatment. Join host Julia Cartwright as she decodes the science, clinical trial results, and real-world access barriers behind this revolutionary injection. Each episode stands alone, exploring a different facet of medicine's newest metabolic game-changer. For more content like this, visit QuietPlease.ai

Explore the groundbreaking science behind GLP-1 drugs and addiction with Dr. Ben Synth. From shared brain reward pathways to landmark veteran studies, discover how medications for diabetes and weight loss may revolutionize treatment for alcohol, opioid, nicotine, and gambling addiction. Evidence-based insights into psychiatry's most promising frontier. For more content like this, visit QuietPlease.ai

Eli Lilly's orforglipron achieved 27 pounds of weight loss in trials, potentially revolutionizing obesity treatment with a daily pill that needs no refrigeration. Dr. Ben Synth examines the science behind oral GLP-1 drugs, their potential to democratize access worldwide, and the dangers of unregulated compounded alternatives that harmed hundreds of patients. For more content like this, visit QuietPlease.ai

When bariatric surgery doesn't maintain weight loss long-term, can Ozempic fill the gap—or does stacking two powerful interventions create dangerous new risks? Dr. Ben Synth unpacks the clinical evidence, patient outcomes, and medical debate surrounding this controversial weight-loss combination. For more content like this, visit QuietPlease.ai

Miss Olivia Harper investigates whether GLP-1 drugs like Ozempic and Wegovy belong in pediatric medicine, exploring clinical trial data, doctor perspectives, and the real-world stakes for teens navigating obesity, identity, and a treatment with unknown long-term effects. For more content like this, visit QuietPlease.ai

Host Julia Cartwright dissects official medical reports and boasts about cognitive tests, consulting independent doctors to separate political spin from clinical reality. What do Trump's health disclosures reveal—and what critical information remains hidden as the oldest president in history governs into his eighties? For more content like this, visit QuietPlease.ai

Maxwell Slate investigates bombshell claims that Trump made false statements disconnected from reality during cabinet meetings, separating lies from possible memory failure. Through clinical analysis of confabulation, fact-checker documentation, and ethical debates over remote diagnosis, the series asks whether fiction in the Cabinet Room signals deliberate deception or something far more troubling. For more content like this, visit QuietPlease.ai

Dr. Ben Synth reveals why up to 15% of patients see little benefit from Ozempic and similar GLP-1 medications, exploring genetic factors, gut microbiome differences, and real-world adherence challenges. Discover the cutting-edge science explaining who responds to these blockbuster weight-loss drugs and who doesn't. For more content like this, visit QuietPlease.ai

Discover why the identical molecule semaglutide exists as two blockbuster drugs with different names, doses, and purposes. Julia Cartwright demystifies Ozempic and Wegovy, revealing the FDA approvals, dosing strategies, insurance battles, and clinical evidence that separate diabetes treatment from weight management. For more content like this, visit QuietPlease.ai

THE SLEEP CURE is an immersive 8-hour deep sleep soundscape designed to gently guide your mind and body into profound relaxation, peaceful dreams, and uninterrupted rest. Created for those who struggle with insomnia, racing thoughts, stress, or restless nights, this all-night audio experience helps your nervous system slow down and your mind drift into calm stillness. At the heart of this sound journey lies the 432 Hz frequency, a tone widely associated with relaxation and emotional harmony.

Modern life overstimulates the nervous system. When the sympathetic "fight-or-flight" response stays active, deep sleep becomes difficult. Feel Good All Night is designed to support parasympathetic activation using carefully engineered delta-frequency binaural beats. Delta brainwaves (0.5–4 Hz) are associated with deep, restorative sleep, cellular recovery, and nervous system regulation. This collection includes 21 continuous-flow tracks with running times between 30 and 150 minutes, allowing flexible use for sleep onset, full-night listening, or extended relaxation sessions.

Host Julia Cartwright explores how GLP-1 drugs are emerging as a potential game-changer for women with polycystic ovary syndrome, a condition where insulin resistance, weight gain, and hormonal imbalance fuel each other in a relentless cycle. Each episode examines how these medications may help break that cycle and restore metabolic and reproductive health. For more content like this, visit QuietPlease.ai

Chronically Cece is the podcast where we tackle chronic illness with a healthy dose of humor and a side of ibuprofen. Join Felicia as she share personal stories, hilarious moments, and the daily rollercoaster of living with pain—because why not laugh through it all? If you've ever found yourself in a battle with your body (and your heating pad), this is your place. Tune in for laughs, real talk, and a reminder that you're not alone in this wild ride. Pain’s inevitable, but so are the laughs... and your favorite anti inflammatory.Join us at chronicallyceceblog.wordpress.com and on Patreon ...

His study significantly shapes our understanding of glioblastoma treatment by introducing an innovative approach that combines photodynamic therapy (PDT) with necroptosis induction. By targeting glioblastoma stem cells—those most resistant to conventional therapies—this method offers new possibilities for more precise surgical outcomes, reduced recurrence, and the development of personalised treatment strategies. Findings demonstrate that inducing necroptosis, a regulated form of cell death, following PDT could bring about notable clinical benefits, particularly by addressing glioblastoma...

Helping you as an expecting expat feel more prepared and confident on your pregnancy journey in the Netherlands. We're here to guide you through what to expect and make you aware of the resources available-so you never feel alone in this experience.